rs146770430

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_033087.4(ALG2):​c.475A>G​(p.Ile159Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000809 in 1,614,172 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00060 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00083 ( 3 hom. )

Consequence

ALG2
NM_033087.4 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:7

Conservation

PhyloP100: 1.69

Publications

7 publications found
Variant links:
Genes affected
ALG2 (HGNC:23159): (ALG2 alpha-1,3/1,6-mannosyltransferase) This gene encodes a member of the glycosyltransferase 1 family. The encoded protein acts as an alpha 1,3 mannosyltransferase, mannosylating Man(2)GlcNAc(2)-dolichol diphosphate and Man(1)GlcNAc(2)-dolichol diphosphate to form Man(3)GlcNAc(2)-dolichol diphosphate. Defects in this gene have been associated with congenital disorder of glycosylation type Ih (CDG-Ii). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2008]
ALG2 Gene-Disease associations (from GenCC):
  • congenital myasthenic syndrome 14
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • ALG2-congenital disorder of glycosylation
    Inheritance: Unknown, AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, PanelApp Australia, Orphanet, Ambry Genetics
  • congenital myasthenic syndromes with glycosylation defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.015303463).
BP6
Variant 9-99218710-T-C is Benign according to our data. Variant chr9-99218710-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 390397.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000604 (92/152286) while in subpopulation EAS AF = 0.000771 (4/5190). AF 95% confidence interval is 0.000304. There are 1 homozygotes in GnomAd4. There are 46 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 3 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG2NM_033087.4 linkc.475A>G p.Ile159Val missense_variant Exon 2 of 2 ENST00000476832.2 NP_149078.1 Q9H553-1A0A024R184
ALG2XM_047423996.1 linkc.196A>G p.Ile66Val missense_variant Exon 2 of 2 XP_047279952.1
ALG2NR_024532.2 linkn.682A>G non_coding_transcript_exon_variant Exon 3 of 3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG2ENST00000476832.2 linkc.475A>G p.Ile159Val missense_variant Exon 2 of 2 1 NM_033087.4 ENSP00000417764.1 Q9H553-1
ALG2ENST00000319033.7 linkc.196A>G p.Ile66Val missense_variant Exon 2 of 2 1 ENSP00000326609.6 Q9H553-2
ALG2ENST00000238477.5 linkn.*217A>G non_coding_transcript_exon_variant Exon 3 of 3 2 ENSP00000432675.2 A0A0A0MTE0
ALG2ENST00000238477.5 linkn.*217A>G 3_prime_UTR_variant Exon 3 of 3 2 ENSP00000432675.2 A0A0A0MTE0

Frequencies

GnomAD3 genomes
AF:
0.000605
AC:
92
AN:
152168
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000524
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.000769
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000426
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000720
AC:
181
AN:
251480
AF XY:
0.000773
show subpopulations
Gnomad AFR exome
AF:
0.000554
Gnomad AMR exome
AF:
0.000173
Gnomad ASJ exome
AF:
0.00694
Gnomad EAS exome
AF:
0.000326
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000527
Gnomad OTH exome
AF:
0.00277
GnomAD4 exome
AF:
0.000830
AC:
1214
AN:
1461886
Hom.:
3
Cov.:
31
AF XY:
0.000851
AC XY:
619
AN XY:
727244
show subpopulations
African (AFR)
AF:
0.000657
AC:
22
AN:
33480
American (AMR)
AF:
0.000291
AC:
13
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00681
AC:
178
AN:
26136
East Asian (EAS)
AF:
0.00416
AC:
165
AN:
39700
South Asian (SAS)
AF:
0.000452
AC:
39
AN:
86258
European-Finnish (FIN)
AF:
0.0000936
AC:
5
AN:
53418
Middle Eastern (MID)
AF:
0.00451
AC:
26
AN:
5768
European-Non Finnish (NFE)
AF:
0.000613
AC:
682
AN:
1112006
Other (OTH)
AF:
0.00139
AC:
84
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
81
161
242
322
403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000604
AC:
92
AN:
152286
Hom.:
1
Cov.:
33
AF XY:
0.000618
AC XY:
46
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.000409
AC:
17
AN:
41564
American (AMR)
AF:
0.000523
AC:
8
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3470
East Asian (EAS)
AF:
0.000771
AC:
4
AN:
5190
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4810
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000426
AC:
29
AN:
68016
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00136
Hom.:
1
Bravo
AF:
0.000672
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000601
AC:
73
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000709
EpiControl
AF:
0.00136

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:7
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:4
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ALG2: BP4 -

May 02, 2018
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

ALG2-congenital disorder of glycosylation;C4015597:Congenital myasthenic syndrome 14 Uncertain:1Benign:1
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ALG2-related disorder Benign:1
Mar 23, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

See cases Benign:1
Apr 08, 2020
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACMG classification criteria: BP1, BP4 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.080
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
14
DANN
Benign
0.67
DEOGEN2
Benign
0.18
T;.
Eigen
Benign
-0.59
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.70
D
LIST_S2
Benign
0.76
T;T
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.015
T;T
MetaSVM
Benign
-0.83
T
MutationAssessor
Uncertain
2.2
M;.
PhyloP100
1.7
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.82
N;N
REVEL
Benign
0.11
Sift
Benign
0.12
T;T
Sift4G
Benign
0.18
T;T
Polyphen
0.090
B;B
Vest4
0.12
MVP
0.50
MPC
0.18
ClinPred
0.0075
T
GERP RS
1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.097
gMVP
0.71
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146770430; hg19: chr9-101980992; COSMIC: COSV105038239; COSMIC: COSV105038239; API